-
Notifications
You must be signed in to change notification settings - Fork 39
Lynch (2022)
Link to CGM data - Must enter name, email, institution, and purpose upon download.
The current study focused to evaluate the transition of Type 1 diabetes management from a hybrid closed-loop system using an insulin pump and CGM to a biotic pancreas. The Dexcom G6 CGM was used across a population group aged between 6 and 71 years over a 13-week period, with a sample size of 90 participants. These 90 participants were part of an initial randomized controlled trial (RCT) focusing on insulin-only biotic pancreas (BP) systems, selected from a broader cohort of approximately 440 enrolled patients, as part of a stage-by-stage study design.
| Sample size | Diabetes Type | Population Group | CGM device | Duration |
|---|---|---|---|---|
| 90 | Type 1 | Adults and children (6-71 years) | Dexcom G6 | 13 weeks |
Below is a script to pre-process the CGM data:
This data set comes with the following data use agreement:
Data collected for this study will be analyzed and stored at the Coordinating Center. After the study is completed, the de-identified, archived data will be archived at the Jaeb Center. A publicly-accessible, de-identified dataset will be made available on the Jaeb Center website and/or the NIDDK data repository.
The above use agreement comes from the JAEB website and study.